NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function

Por You, Weon-Kyoo, Yotsumoto, Fusanori, Sakimura, Kenji, Adams, Ralf H., Stallcup, William B.
Publicado em 2013

NG2 PROTEOGLYCAN-DEPENDENT CONTRIBUTIONS OF PERICYTES AND MACROPHAGES TO BRAIN TUMOR VASCULARIZATION AND PROGRESSION

Por Stallcup, William B., You, Weon-Kyoo, Kucharova, Karolina, Cejudo-Martin, Pilar, Yotsumoto, Fusanori
Publicado no Microcirculation (2016)

Warburg effect regulated by amphiregulin in the development of colorectal cancer

Por Nam, Sung Ouk, Yotsumoto, Fusanori, Miyata, Kohei, Fukagawa, Satoshi, Yamada, Hiromi, Kuroki, Masahide, Miyamoto, Shingo
Publicado no Cancer Med (2015)

NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization

Por Yotsumoto, Fusanori, You, Weon-Kyoo, Cejudo-Martin, Pilar, Kucharova, Karolina, Sakimura, Kenji, Stallcup, William B
Publicado no Oncoimmunology (2015)

Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer

Por Kasai, Noriyuki, Kobayashi, Kazuhiro, Shioya, Shinobu, Yoshikawa, Yukitaka, Yotsumoto, Fusanori, Miyamoto, Shingo, Mekada, Eisuke, Enokizono, Junichi
Publicado em 2012

A case of secondary amenorrhea caused by uterine myoma successfully treated by a combined laparoscopic and hysteroscopic approach

Por Shirota, Kyoko, Itoh, Hiroko, Anan, Haruchika, Natsuaki, Shimpei, Miyahara, Daisuke, Takahashi, Yoko, Yotsumoto, Fusanori, Miyamoto, Shingo
Publicado no Gynecol Minim Invasive Ther (2017)

A partial supernumerary umbilical vein: a case report

Por Kurakazu, Mariko, Kurakazu, Masamitsu, Murata, Masaharu, Miyamoto, Tatsuki, Takahashi, Yoko, Hamasaki, Makoto, Ohta, Eiji, Yotsumoto, Fusanori, Miyamoto, Shingo
Publicado no J Med Case Rep (2019)

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma

Por Miyata, Kohei, Yotsumoto, Fusanori, Nam, Sung Ouk, Odawara, Takashi, Manabe, Sadao, Ishikawa, Toyokazu, Itamochi, Hiroaki, Kigawa, Junzo, Takada, Shuji, Asahara, Hiroshi, Kuroki, Masahide, Miyamoto, Shingo
Publicado no Cancer Med (2014)

MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer

Por Fukagawa, Satoshi, Miyata, Kohei, Yotsumoto, Fusanori, Kiyoshima, Chihiro, Nam, Sung Ouk, Anan, Haruchika, Katsuda, Takahiro, Miyahara, Daisuke, Murata, Masaharu, Yagi, Hiroshi, Shirota, Kyoko, Yasunaga, Shin'ichiro, Kato, Kiyoko, Miyamoto, Shingo
Publicado no Cancer Sci (2017)

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome

Por Urushiyama, Daichi, Suda, Wataru, Ohnishi, Eriko, Araki, Ryota, Kiyoshima, Chihiro, Kurakazu, Masamitsu, Sanui, Ayako, Yotsumoto, Fusanori, Murata, Masaharu, Nabeshima, Kazuki, Yasunaga, Shin’ichiro, Saito, Shigeru, Nomiyama, Makoto, Hattori, Masahira, Miyamoto, Shingo, Hata, Kenichiro
Publicado no Sci Rep (2017)

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

Por Miyamoto, Shingo, Yotsumoto, Fusanori, Ueda, Taeko, Fukami, Tatsuya, Sanui, Ayako, Miyata, Kohei, Nam, Sung Ouk, Fukagawa, Satoshi, Katsuta, Takahiro, Maehara, Miyako, Kondo, Haruhiko, Miyahara, Daisuke, Shirota, Kyoko, Yoshizato, Toshiyuki, Kuroki, Masahide, Nishikawa, Hiroaki, Saku, Keijiro, Tsuboi, Yoshio, Ishitsuka, Kenji, Takamatsu, Yasushi, Tamura, Kazuo, Matsunaga, Akira, Hachisuga, Toru, Nishino, Shinsuke, Odawara, Takashi, Maeda, Kazuhiro, Manabe, Sadao, Ishikawa, Toyokazu, Okuno, Yoshinobu, Ohishi, Minako, Hikita, Tomoya, Mizushima, Hiroto, Iwamoto, Ryo, Mekada, Eisuke
Publicado no BMC Cancer (2017)